(2020). Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
Chicago Style (17th ed.) CitationPrevalence of COVID-19 Among Patients with Chronic Inflammatory Rheumatic Diseases Treated with Biologic Agents or Small Molecules: A Population-based Study in the First Two Months of COVID-19 Outbreak in Italy. 2020.
MLA (8th ed.) CitationPrevalence of COVID-19 Among Patients with Chronic Inflammatory Rheumatic Diseases Treated with Biologic Agents or Small Molecules: A Population-based Study in the First Two Months of COVID-19 Outbreak in Italy. 2020.
Warning: These citations may not always be 100% accurate.